Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

International Journal of Cancer. Journal International Du Cancer
M Aguilar-SantelisesMikael Jondal

Abstract

Our previous data have shown that isolated leukemic cells from progressive chronic lymphocytic leukemia (B-CLL) patients respond to growth stimulation in vitro and express high levels of p53, immunoreactive with the configuration-specific antibody PAb 240. We have now analyzed the in vitro survival of B-CLL cells in relation to Bcl-2, Bax alpha and p53 expression and compared this with the clinical progression of the disease. Leukemic cells from patients with progressive disease demonstrated higher in vitro survival, compared with non-progressive B-CLL and normal B cells. All cells were sensitive to treatment with a combination of glucocorticoid and cAMP. Bcl-2 protein levels were not related to clinical progression, as measured by flow cytometry. Competitive PCR showed that Bcl-2 mRNA was over-expressed in most of the B-CLL samples and that p53 mRNA expression was similar between B-CLL groups and normal values and thus not related to clinical progression. However, since Bax alpha expression was lower in progressive than in non-progressive patients, the Bcl-2/Bax alpha ratio at the mRNA level was significantly higher in the progressive group. Our data suggest that the Bcl-2/Bax alpha ratio is important for the regulation of B-C...Continue Reading

References

Jan 1, 1978·American Journal of Hematology·R T SilverO Glidewell
Oct 8, 1992·Nature·P D Siebert, J W Larrick
Aug 1, 1992·Immunology Today·S J Korsmeyer
Apr 1, 1990·Immunology Today·D J McConkeyM Jondal
Nov 25, 1988·Nucleic Acids Research·M Wilkinson
Jun 21, 1985·Science·Y TsujimotoC M Croce
Oct 22, 1993·Cell·D M HockenberyS J Korsmeyer
Dec 1, 1994·Immunology Today·G NúñezM González-García
Aug 15, 1994·International Journal of Cancer. Journal International Du Cancer·M Aguilar-SantelisesM Jondal
May 26, 1994·Nature·A H Wyllie
Feb 11, 1994·Science·M Barinaga
Apr 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D J McConkeyM Jondal
Feb 1, 1992·Current Biology : CB·A L DeFranco

❮ Previous
Next ❯

Citations

Sep 24, 2011·Advances in Hematology·Flora TzifiAndreas Scorilas
Nov 25, 2000·British Journal of Haematology·Y L OngA E Irvine
Aug 26, 1998·Leukemia & Lymphoma·L M OsorioM Aguilar-Santelises
Jun 1, 1999·Leukemia & Lymphoma·E CombyM Leporrier
Apr 16, 2003·European Journal of Haematology·Yonit BomsteinMichael Lishner
Jul 29, 2006·Cell Proliferation·J G MahdiD Humam
May 6, 2004·Journal of the National Cancer Institute·Oksana MoshynskaAnurag Saxena
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk L KienleStephan Stilgenbauer
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rajat BannerjiJohn C Byrd
Feb 28, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J R FariaJ S R Oliveira
Jun 17, 1998·International Journal of Cancer. Journal International Du Cancer·N Laytragoon-LewinG Klein
Aug 31, 2002·Hematological Oncology·Gerassimos A PangalisMaria K Angelopoulou
Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
Jun 28, 2001·Leukemia & Lymphoma·J E Parker, G J Mufti
Apr 13, 2004·Journal of Leukocyte Biology·Wassim Y AlmawiMaroun M Abou Jaoude
Oct 23, 2004·International Journal of Cancer. Journal International Du Cancer·Alejo A MoralesLyda M Osorio
May 5, 2006·Annals of Hematology·Jin Tae JungKyu Bo Lee
Feb 10, 1999·Medical Oncology·L M Osorio, M Aguilar-Santelises
Jan 17, 2002·The Journal of Obstetrics and Gynaecology Research·S IshiokaR Kudo
Oct 7, 2003·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jie MaErgu Yao

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.